Terray Therapeutics is using AI-technology to drive drug discovery. To develop a therapeutic engine, Terray is generating chemical data purpose-built for drug discovery that is integrated into their computational platform, tNova. tNova runs iterative cycles of virtual molecular design and precise biochemical measurement. This data feeds forward to power machine learning models that guide the next cycle of design. With a chemistry engine that measures billions of interactions daily and becomes increasingly precise, Terray can answer various biological questions and derive insights to predictably create drugs for patients. This virtual approach enables Terray to work on a large scale, faster than previously possible. 

<p>Terray Therapeutics is using AI-technology to drive drug discovery. To develop a therapeutic engine, Terray is generating chemical data purpose-built for drug discovery that is integrated into their computational platform, tNova. tNova runs iterative cycles of virtual molecular design and precise biochemical measurement. This data feeds forward to power machine learning models that guide the next cycle of design. With a chemistry engine that measures billions of interactions daily and becomes increasingly precise, Terray can answer various biological questions and derive insights to predictably create drugs for patients. This virtual approach enables Terray to work on a large scale, faster than previously possible. </p>


Terray Therapeutics

Founded: 2018
Location: Pasadena, CA
Employee range: 11 - 50
Clinical stage: Clin0
Therapy area: Retinitis pigmentosa
Drug types: OPH, GEN
Lead product: RTx-015
Funding: $60M Feb 2022

Drug notes:

About:

Jobs: